Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SAMSN1 antisense RNA 1 (SAMSN1-AS1) is a long non-coding RNA (lncRNA) gene, classified as part of the lncRNA gene class[3]. It does not encode a protein. There is currently no evidence in the scientific literature or curated gene/protein databases to indicate that SAMSN1-AS1 directly acts as a therapeutic target, receptor, or enzyme. Its precise biological function and protein interactions are not well characterized, and there are no known approved drugs that have been demonstrated to interact with SAMSN1-AS1 or clinical biomarkers involving this lncRNA. Most references refer to the adjacent or sense gene (SAMSN1) in the context of immune regulation or cancer, but not to the antisense RNA itself[3]. Note: - The search results (and current curated databases like GeneCards) provide only gene locus/identity-level information for SAMSN1-AS1 and do not attribute biological, disease, or pharmacological roles[3]. Detailed functional studies may not be published or indexed as of the current search. - This entry is distinct from the protein-coding gene SAMSN1, for which roles in immunity and cancer have been documented[1][4][5]. - No safety, biomarker, or pharmacological relevance has been established for SAMSN1-AS1. Summary: SAMSN1-AS1 is a non-protein-coding long non-coding RNA gene; it is not a currently recognized therapeutic target, nor are there data on its direct involvement in biological functions, disease roles, or drug interactions[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SAMSN1 antisense RNA 1 (SAMSN1-AS1).